• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Med . Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines

tetano

Editor, Senior Moderator
BMC Med


. 2023 Aug 9;21(1):301.
doi: 10.1186/s12916-023-02996-3. Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines

Naomi R Waterlow[SUP] 1 [/SUP], Simon R Procter[SUP] 2 [/SUP], Rosalind M Eggo[SUP] 2 [/SUP], Mark Jit[SUP] 2 [/SUP]



Affiliations
Free PMC article Abstract

We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the wider benefits of vaccination on cost-effectiveness. Whilst we agree with many points raised in the commentary, we think it raises further interesting discussion points, specifically around model complexity, model assumptions and data availability. These points are both relevant to this manuscript but have wider implications for vaccine cost-effectiveness studies.

Keywords: Assumptions; Burden; Complexity; Cost-effectiveness; Influenza; Mathematical modelling; Next-generation vaccines; Vaccines.

 
Back
Top Bottom